Can the pharmaceutical industry reduce attrition rates?
Ismail Kola, John Richard Landis · Nature Reviews Drug Discovery · 2004
Cited by 4,158 works. doi:10.1038/nrd1470
Authors
References
- The price of innovation: new estimates of drug development costs
- BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics
- Cathepsin K Knockout Mice Develop Osteopetrosis Due to a Deficit in Matrix Degradation but Not Demineralization
- Value of novelty?
- Oncology's trials
- An animal model for pycnodysostosis: the role of cathepsin K in bone remodelling
- 2003 approvals: a year of innovation and upward trends